The FDA has determined that the Novavax COVID-19 Vaccine, Adjuvanted has met the statutory criteria for issuance of an EUA. The data support that the known and potential benefits of the vaccine outweigh its known and potential risks in people 18 years of age and older, and that this vaccine may be effective in preventing COVID-19. In making this determination, the FDA can assure the public and medical community that a thorough analysis and evaluation of the available safety and effectiveness data and manufacturing information have been conducted.
You just need to love the FDA and the use of words like 'May'
The FDA has determined that the Novavax COVID-19 Vaccine,...
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.015(1.53%) |
Mkt cap ! $1.167B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $3.168M | 3.120M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 101529 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 93796 | 37 |
View Market Depth
| Last trade - 13.27pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |